Clinical Trials Directory

Trials / Completed

CompletedNCT02760420

3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi

Double-blind Randomized Controlled Clinical Trial of 3 Days of Amoxicillin Disperable Tablet (DT) Versus Placebo for Fast Breathing Childhood Pneumonia Among Children 2-59 Months of Age Presenting to Kamuzu Central Hospital in Lilongwe, Malawi

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
1,126 (actual)
Sponsor
Save the Children · Academic / Other
Sex
All
Age
2 Months – 59 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study to assess the effectiveness of no antibiotic treatment for fast breathing, community-acquired childhood pneumonia in a malaria-endemic region of Malawi.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillinOral amoxicillin dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily
DRUGPlaceboOral placebo dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

Timeline

Start date
2016-06-01
Primary completion
2019-03-01
Completion
2019-06-01
First posted
2016-05-03
Last updated
2021-02-18

Locations

2 sites across 1 country: Malawi

Source: ClinicalTrials.gov record NCT02760420. Inclusion in this directory is not an endorsement.